← FDA Drug Approvals (Drugs@FDA)

VASOPRESSIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2023-12-06

Drug application

FDA Application #

ANDA217987

Application type

Abbreviated New Drug Application (Generic)

Brand name

VASOPRESSIN

Generic name

Vasopressin

Active ingredients

VASOPRESSIN

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

CIPLA

First approval

2023-12-06

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown